As of 2024-12-13, the Fair Value of Pulmonx Corp (LUNG) is -7.23 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 6.05 USD, the upside of Pulmonx Corp is -219.51%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -20.70 | -32.23 | -48.66 | -58.92 | -60.84 | -44.27 |
| YoY growth | -12.01% | -55.70% | -50.98% | -21.09% | -3.26% | -28.61% |
| Market Cap (mil) | 238.91 |
| P/E | |
| Forward P/E |
| EPS | -1.45 |
| Avg earnings growth rate | -28.61% |
| TTM earnings | -57.11 |